Friday a Kentucky court ruled that the records regarding Purdue Pharma’s marketing strategies of its opioid drug, OxyContin must be made public, offering a critical Incite into the company’s practices. A three-judge panel ruled the deposition of Richard Sackler, the former president of Purdue Pharma must be unsealed, including about 17 million pages of other documents that […]
The post Purdue Pharma’s Unsealed Documents May Detail How Company Downplayed Oxycontin Risk appeared first on The Recover.
source https://www.therecover.com/purdue-pharmas-unsealed-documents-may-detail-how-company-downplayed-oxycontin-risk/
No comments:
Post a Comment